Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 37 | April McClain DelaneyDDependent child | Sale | SELL | $100K – $250K |
| Sep 9, 2026 traded Aug 25, 2026 |
| 36 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $101K 13.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | April McClain DelaneyDDependent child | Sale | SELL | $250K – $500K | Sep 9, 2026 traded Aug 25, 2026 |
| 35 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $989K 23.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 35 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $485K 5,386 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | April McClain DelaneyDDependent child | Sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 3, 2026 |
| 35 | Dotan SaarEVP Countries & BD | Open-market sale | SELL | $88K 2,890 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Brandon GillRSelf | RSP ETF Purchase | BUY | $50K – $100K | Sep 9, 2026 traded Aug 13, 2026 |
| 34 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $6.98M 464.2K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Sluis FrankCFO | Open-market sale | SELL | $19K 687 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 33 | April McClain DelaneyDDependent child | Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 32 | Chin Peter ScottChief Medical Officer | Open-market sale | SELL | $37K 1,654 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Maria Elvira SalazarRSelf | Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 24, 2026 |
| 32 | Maria Elvira SalazarRSelf | Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 24, 2026 |
| 32 | Lindgardt ZhenyaDirector, Chief Executive Officer | Open-market sale | SELL | $40K 20.1K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Dotan SaarEVP Countries & BD | Open-market sale | SELL | $24K 800 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Clerc AlexandreSVP, Customers | Open-market sale | SELL | $20K 3,480 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,590 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 31 | April McClain DelaneyDDependent child | Partial sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 6, 2026 |
| 31 | Maria Elvira SalazarRSelf | Sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 19, 2026 |
| 31 | April McClain DelaneyDDependent child | Sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 25, 2026 |
| 31 | April McClain DelaneyDDependent child | Sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 7, 2026 |
| 31 | April McClain DelaneyDDependent child | Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 5, 2026 |
| 31 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $458K 5,387 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $793K 17.9K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $518K 11.7K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | April McClain DelaneyDDependent child | Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 30 | April McClain DelaneyDDependent child | Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 56 | Cheng LawrenceDirector | Open-market purchase | BUY | $1.03M 55.0K sh | Sep 8, 2026 traded Sep 8, 2026 |
| 56 | Marks Peter AshleyDirector | Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 56 | Stamler David AllenDirector, Chief Executive Officer | Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 52 | Marks Peter AshleyDirector | Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 51 | Roeder Clinton WilliamChief Financial Officer | Open-market purchase | BUY | $221K 8,000 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 51 | Speth RalfDirector | Open-market purchase | BUY | $114K 35.0K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 48 | Meyer-Gloeckner Birger JohannesDirector | Open-market sale | SELL | $44K 1,531 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 46 | Wambeke David J.Chief Business Officer | Open-market purchase | BUY | $67K 33.3K sh | Sep 8, 2026 traded Aug 27, 2026 |
| 46 | ADAR1 Capital Management, LLC10% Owner | Open-market purchase | BUY | $1.60M 900.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 43 | Speth RalfDirector | Open-market purchase | BUY | $101K 33.0K sh | Sep 8, 2026 traded Sep 2, 2026 |